Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,755 | -$52,731 | -$67,992 | -$58,819 |
| Dep. & Amort. | $23 | $19 | $157 | $157 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,980 | $7,165 | $9,324 | $9,903 |
| Change in WC | $4,483 | -$7,604 | -$525 | -$1,356 |
| Other Non-Cash | -$364 | $747 | -$412 | -$225 |
| Operating Cash Flow | -$46,633 | -$52,404 | -$59,448 | -$50,340 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $84 | $0 | $0 |
| Inv. Purchases | $0 | -$39,379 | -$44,385 | -$106,899 |
| Inv. Sales/Matur. | $51,246 | $68,796 | $88,545 | $8,100 |
| Other Inv. Act. | $71 | $896 | $0 | $0 |
| Investing Cash Flow | $51,317 | $30,397 | $44,160 | -$98,799 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$136 | $18,398 | $0 | $0 |
| Stock Issued | $0 | $59 | $0 | $13,694 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,879 |
| Financing Cash Flow | -$136 | $18,457 | $0 | $15,573 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,548 | -$3,550 | -$15,288 | -$133,566 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $124,523 | $128,073 | $143,361 | $276,927 |
| End Cash | $129,071 | $124,523 | $128,073 | $143,361 |
| Free Cash Flow | -$46,649 | -$52,404 | -$59,448 | -$50,340 |